Skip to main content

Table 1 Distribution of AEs across different age groups

From: Variable importance for projection (VIP) scores for analyzing the contribution of risk factors in severe adverse events to Xiyanping injection

 

Children (0–6 years old)

Adolescents (7–17 years old)

Young adults (18–40 years old)

Middle-aged adults (41–65 years old)

Older adults (> 65 years old)

 

General AEs

Severe AEs

General AEs

Severe AEs

General AEs

Severe AEs

General AEs

Severe AEs

General AEs

Severe AEs

XYP

9763(0.96)

410(0.04)

2495(0.95)

126(0.04)

2706(0.95)

146(0.05)

3062(0.95)

177(0.05)

1627(0.92)

132(0.08)

RB

92(0.93)

7(0.07)

8(0.89)

1(0.11)

10(0.83)

2(0.17)

8(0.89)

1(0.11)

7(0.88)

1(0.13)

CTR

136(0.96)

5(0.04)

33(0.94)

2(0.06)

4(0.80)

1(0.20)

7(0.78)

2(0.22)

4(1)

0(0)

PS

9(1)

0(0)

3(1)

0(0)

4(0.80)

1(0.20)

1(1)

0(0)

2(0.67)

1(0.33)

AH

23(0.96)

1(0.04)

0(0)

0(0)

0(0)

0(0)

0(0)

0(0)

6(0.86)

1(0.14)

DA

39(0.93)

3(0.07)

19(0.95)

1(0.05)

24(0.92)

2(0.08)

15(0.88)

2(0.12)

15(0.94)

1(0.06)

FOX

10(1)

0(0)

6(1)

0(0)

0(0)

0(0)

0(0)

0(0)

0(0)

0(0)

AZM

141(0.96)

6(0.04)

51(0.98)

1(0.02)

25(0.96)

1(0.04)

15(0.88)

2(0.12)

10(0.91)

1(0.09)

CAZ

57(0.93)

4(0.07)

14(0.93)

1(0.07)

1(1)

0(0)

6(0.75)

2(0.25)

8(1)

0(0)

AMC

39(0.95)

2(0.05)

5(1)

0(0)

0(0)

0(0)

3(0.75)

1(0.25)

2(1)

0(0)

LEVH

3(1)

0(0)

0(0)

0(0)

54(0.95)

3(0.05)

45(0.94)

3(0.06)

24(0.96)

1(0.04)

CSP

8(1)

0(0)

0(0)

0(0)

0(0)

0(0)

1(1)

0(0)

0(0)

0(0)

ACY

5(1)

0(0)

0(0)

0(0)

2(1)

0(0)

2(1)

0(0)

1(1)

0(0)

  1. n = The percentage was calculated by dividing the total number of cases by the number of AE cases for each level